InfuSystem Holdings, Inc. (NYSE:INFU – Get Free Report) has been assigned a consensus rating of “Buy” from the five research firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $14.50.
Several research analysts recently commented on INFU shares. Zacks Research downgraded InfuSystem from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 6th. Roth Mkm reiterated a “buy” rating and issued a $14.00 target price (up from $13.00) on shares of InfuSystem in a research report on Tuesday, November 4th.
Check Out Our Latest Report on InfuSystem
Institutional Inflows and Outflows
InfuSystem Price Performance
NYSE:INFU opened at $8.65 on Friday. The firm has a market cap of $175.91 million, a P/E ratio of 144.19 and a beta of 1.68. The stock has a 50 day moving average of $9.04 and a two-hundred day moving average of $8.98. InfuSystem has a 12 month low of $4.61 and a 12 month high of $11.04. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.
About InfuSystem
InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem’s offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.
In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.
Read More
- Five stocks we like better than InfuSystem
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for InfuSystem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InfuSystem and related companies with MarketBeat.com's FREE daily email newsletter.
